← Back to Search

Behavioral Intervention

ADSTEP for Multiple Sclerosis (ADSTEP Trial)

N/A
Waitlist Available
Led By Michelle Cameron, PT, MD, MCR
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, 8 weeks, and 8 months
Awards & highlights

ADSTEP Trial Summary

This trial is testing a training program to see if it reduces falls for people who use a hand-held walking aid.

ADSTEP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 8 weeks, and 8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 8 weeks, and 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in Self-Reported Falls at 8 months
Secondary outcome measures
Change from Baseline in Functional Gait Assessment / Dynamic Gait Index
Other outcome measures
Change from Baseline in Physical Activity
Change from Baseline in Quality of Life
Change from Baseline in Walking Ability
+1 more

ADSTEP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: trainingExperimental Treatment1 Intervention
The subjects receive the ADSTEP intervention
Group II: waitlistActive Control1 Intervention
These subjects receive two brochures on fall prevention and walking aid selection, and a letter is sent to their care provider informing them that the subject has reported falling. Subjects in this group will be offered the ADSTEP intervention once their study participation is complete.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ADSTEP
2020
N/A
~80

Find a Location

Who is running the clinical trial?

Portland VA Medical CenterFED
41 Previous Clinical Trials
7,264 Total Patients Enrolled
5 Trials studying Multiple Sclerosis
289 Patients Enrolled for Multiple Sclerosis
Oregon Health and Science UniversityLead Sponsor
973 Previous Clinical Trials
7,385,734 Total Patients Enrolled
29 Trials studying Multiple Sclerosis
2,138 Patients Enrolled for Multiple Sclerosis
Michelle Cameron, PT, MD, MCR2.33 ReviewsPrincipal Investigator - Oregon Health & Science University / VA Portland Health Care System
Oregon Health and Science University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are you currently seeking participants for this experiment?

"As detailed on clinicaltrials.gov, this medical study is not currently enrolling participants. The experiment was posted to the website on February 6th 2020 and its last update happened in November 7th 2022. While it's presently closed for enrollment, there are 393 other trials actively recruiting patients at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Randomized Controlled Trial of a Multicomponent Walking Aid Program for People With MS
Michelle Cameron 2020. "A Randomized Controlled Trial of a Multicomponent Walking Aid Program for People With MS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04145934.
~15 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top